HEADER TRANSCRIPTION 28-JUL-08 2VYT TITLE THE MBT REPEATS OF HUMAN SCML2 BIND TO PEPTIDES CONTAINING MONO TITLE 2 METHYLATED LYSINE. COMPND MOL_ID: 1; COMPND 2 MOLECULE: SEX COMB ON MIDLEG-LIKE PROTEIN 2; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: MBT REPEATS, RESIDUES 24-243; COMPND 5 SYNONYM: SCML2, HUMAN MBT; COMPND 6 ENGINEERED: YES; COMPND 7 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 6 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 7 EXPRESSION_SYSTEM_VARIANT: C41; SOURCE 8 EXPRESSION_SYSTEM_VECTOR: MODIFIED PRSETA KEYWDS MONO METHYLATED PEPTIDES, MBT REPEATS, TRANSCRIPTION, PHOSPHOPROTEIN, KEYWDS 2 ALTERNATIVE SPLICING, TRANSCRIPTION REGULATION, NUCLEUS, REPRESSOR, KEYWDS 3 CHROMATIN, HUMAN SCML2 EXPDTA X-RAY DIFFRACTION AUTHOR C.M.SANTIVERI,B.C.LECHTENBERG,M.D.ALLEN,A.SATHYAMURTHY,A.M.JAULENT, AUTHOR 2 S.M.V.FREUND,M.BYCROFT REVDAT 5 13-DEC-23 2VYT 1 REMARK REVDAT 4 24-JAN-18 2VYT 1 SOURCE REVDAT 3 24-FEB-09 2VYT 1 VERSN REVDAT 2 23-SEP-08 2VYT 1 COMPND AUTHOR JRNL REMARK REVDAT 1 05-AUG-08 2VYT 0 JRNL AUTH C.M.SANTIVERI,B.C.LECHTENBERG,M.D.ALLEN,A.SATHYAMURTHY, JRNL AUTH 2 A.M.JAULENT,S.M.V.FREUND,M.BYCROFT JRNL TITL THE MALIGNANT BRAIN TUMOR REPEATS OF HUMAN SCML2 BIND TO JRNL TITL 2 PEPTIDES CONTAINING MONOMETHYLATED LYSINE. JRNL REF J.MOL.BIOL. V. 382 1107 2008 JRNL REFN ISSN 0022-2836 JRNL PMID 18706910 JRNL DOI 10.1016/J.JMB.2008.07.081 REMARK 2 REMARK 2 RESOLUTION. 1.90 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.2 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.90 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 30.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 10000.000 REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 99.6 REMARK 3 NUMBER OF REFLECTIONS : 40481 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : 1 REMARK 3 R VALUE (WORKING SET) : 0.217 REMARK 3 FREE R VALUE : 0.249 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.900 REMARK 3 FREE R VALUE TEST SET COUNT : 2005 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3123 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 32 REMARK 3 SOLVENT ATOMS : 187 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 26.90 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 31.26 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 3.49500 REMARK 3 B22 (A**2) : -4.44300 REMARK 3 B33 (A**2) : 0.94900 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.008 REMARK 3 BOND ANGLES (DEGREES) : 1.444 REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : 0.45 REMARK 3 BSOL : 63.75 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : ION.PARAM REMARK 3 PARAMETER FILE 3 : WATER.PARAM REMARK 3 PARAMETER FILE 4 : NHE.PAR REMARK 3 PARAMETER FILE 5 : PEG.PAR REMARK 3 PARAMETER FILE 6 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 TOPOLOGY FILE 2 : NULL REMARK 3 TOPOLOGY FILE 3 : NULL REMARK 3 TOPOLOGY FILE 4 : NULL REMARK 3 TOPOLOGY FILE 5 : NULL REMARK 3 TOPOLOGY FILE 6 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2VYT COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 28-JUL-08. REMARK 100 THE DEPOSITION ID IS D_1290037046. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 9.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID14-2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9540 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 40544 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.900 REMARK 200 RESOLUTION RANGE LOW (A) : 30.400 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 200 DATA REDUNDANCY : 4.000 REMARK 200 R MERGE (I) : 0.06000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 13.2000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.90 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : 99.9 REMARK 200 DATA REDUNDANCY IN SHELL : 4.10 REMARK 200 R MERGE FOR SHELL (I) : 0.32000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 3.800 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: PDB ENTRY 1OI1 REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 51.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.53 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1M CHES, PH 9.5 40% PEG 600 5MM REMARK 280 MONOMETHYLATD LYSINE 10MM MBT REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 19.26500 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 65.63850 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 49.60500 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 65.63850 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 19.26500 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 49.60500 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 400 REMARK 400 COMPOUND REMARK 400 ENGINEERED RESIDUE IN CHAIN A, LYS 147 TO GLU REMARK 400 ENGINEERED RESIDUE IN CHAIN B, LYS 147 TO GLU REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 23 REMARK 465 SER A 24 REMARK 465 THR A 25 REMARK 465 SER A 26 REMARK 465 SER A 27 REMARK 465 VAL A 28 REMARK 465 GLN A 29 REMARK 465 GLY B 23 REMARK 465 SER B 24 REMARK 465 THR B 25 REMARK 465 SER B 26 REMARK 465 SER B 27 REMARK 465 VAL B 28 REMARK 465 GLN B 29 REMARK 465 ARG B 30 REMARK 465 ASP B 73 REMARK 465 PRO B 74 REMARK 465 ARG B 75 REMARK 465 ASN B 76 REMARK 465 ALA B 77 REMARK 465 LEU B 127 REMARK 465 LEU B 128 REMARK 465 GLN B 129 REMARK 465 PRO B 130 REMARK 465 PRO B 131 REMARK 465 LEU B 132 REMARK 465 GLY B 133 REMARK 465 TYR B 134 REMARK 465 GLN B 135 REMARK 465 MET B 136 REMARK 465 ASN B 137 REMARK 465 THR B 138 REMARK 465 SER B 139 REMARK 465 SER B 140 REMARK 465 TRP B 141 REMARK 465 PRO B 142 REMARK 465 MET B 143 REMARK 465 PHE B 144 REMARK 465 LEU B 145 REMARK 465 LEU B 146 REMARK 465 GLU B 147 REMARK 465 THR B 148 REMARK 465 LEU B 149 REMARK 465 ASN B 150 REMARK 465 GLY B 151 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 PRO B 186 C - N - CA ANGL. DEV. = 9.7 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 76 74.66 -160.88 REMARK 500 PRO A 186 -19.77 -46.30 REMARK 500 THR A 242 71.38 -118.24 REMARK 500 ASP B 32 -13.35 71.79 REMARK 500 ASN B 102 -28.85 72.60 REMARK 500 PRO B 186 -30.23 -37.00 REMARK 500 TYR B 215 148.56 -170.11 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MLZ A1244 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MLZ B1244 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PGE B1245 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1OI1 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE MBT DOMAINS OF HUMAN SCML2 REMARK 900 RELATED ID: 2BIV RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE WILD-TYPE MBT DOMAINS OF HUMAN SCML2 REMARK 999 REMARK 999 SEQUENCE REMARK 999 MUTATION K147E DBREF 2VYT A 23 23 PDB 2VYT 2VYT 23 23 DBREF 2VYT A 24 243 UNP Q9UQR0 SCML2_HUMAN 24 243 DBREF 2VYT B 23 23 PDB 2VYT 2VYT 23 23 DBREF 2VYT B 24 243 UNP Q9UQR0 SCML2_HUMAN 24 243 SEQADV 2VYT GLU A 147 UNP Q9UQR0 LYS 147 ENGINEERED MUTATION SEQADV 2VYT GLU B 147 UNP Q9UQR0 LYS 147 ENGINEERED MUTATION SEQRES 1 A 221 GLY SER THR SER SER VAL GLN ARG ASP ASP PHE HIS TRP SEQRES 2 A 221 GLU GLU TYR LEU LYS GLU THR GLY SER ILE SER ALA PRO SEQRES 3 A 221 SER GLU CYS PHE ARG GLN SER GLN ILE PRO PRO VAL ASN SEQRES 4 A 221 ASP PHE LYS VAL GLY MET LYS LEU GLU ALA ARG ASP PRO SEQRES 5 A 221 ARG ASN ALA THR SER VAL CYS ILE ALA THR VAL ILE GLY SEQRES 6 A 221 ILE THR GLY ALA ARG LEU ARG LEU ARG LEU ASP GLY SER SEQRES 7 A 221 ASP ASN ARG ASN ASP PHE TRP ARG LEU VAL ASP SER PRO SEQRES 8 A 221 ASP ILE GLN PRO VAL GLY THR CYS GLU LYS GLU GLY ASP SEQRES 9 A 221 LEU LEU GLN PRO PRO LEU GLY TYR GLN MET ASN THR SER SEQRES 10 A 221 SER TRP PRO MET PHE LEU LEU GLU THR LEU ASN GLY SER SEQRES 11 A 221 GLU MET ALA SER ALA THR LEU PHE LYS LYS GLU PRO PRO SEQRES 12 A 221 LYS PRO PRO LEU ASN ASN PHE LYS VAL GLY MET LYS LEU SEQRES 13 A 221 GLU ALA ILE ASP LYS LYS ASN PRO TYR LEU ILE CYS PRO SEQRES 14 A 221 ALA THR ILE GLY ASP VAL LYS GLY ASP GLU VAL HIS ILE SEQRES 15 A 221 THR PHE ASP GLY TRP SER GLY ALA PHE ASP TYR TRP CYS SEQRES 16 A 221 LYS TYR ASP SER ARG ASP ILE PHE PRO ALA GLY TRP CYS SEQRES 17 A 221 ARG LEU THR GLY ASP VAL LEU GLN PRO PRO GLY THR SER SEQRES 1 B 221 GLY SER THR SER SER VAL GLN ARG ASP ASP PHE HIS TRP SEQRES 2 B 221 GLU GLU TYR LEU LYS GLU THR GLY SER ILE SER ALA PRO SEQRES 3 B 221 SER GLU CYS PHE ARG GLN SER GLN ILE PRO PRO VAL ASN SEQRES 4 B 221 ASP PHE LYS VAL GLY MET LYS LEU GLU ALA ARG ASP PRO SEQRES 5 B 221 ARG ASN ALA THR SER VAL CYS ILE ALA THR VAL ILE GLY SEQRES 6 B 221 ILE THR GLY ALA ARG LEU ARG LEU ARG LEU ASP GLY SER SEQRES 7 B 221 ASP ASN ARG ASN ASP PHE TRP ARG LEU VAL ASP SER PRO SEQRES 8 B 221 ASP ILE GLN PRO VAL GLY THR CYS GLU LYS GLU GLY ASP SEQRES 9 B 221 LEU LEU GLN PRO PRO LEU GLY TYR GLN MET ASN THR SER SEQRES 10 B 221 SER TRP PRO MET PHE LEU LEU GLU THR LEU ASN GLY SER SEQRES 11 B 221 GLU MET ALA SER ALA THR LEU PHE LYS LYS GLU PRO PRO SEQRES 12 B 221 LYS PRO PRO LEU ASN ASN PHE LYS VAL GLY MET LYS LEU SEQRES 13 B 221 GLU ALA ILE ASP LYS LYS ASN PRO TYR LEU ILE CYS PRO SEQRES 14 B 221 ALA THR ILE GLY ASP VAL LYS GLY ASP GLU VAL HIS ILE SEQRES 15 B 221 THR PHE ASP GLY TRP SER GLY ALA PHE ASP TYR TRP CYS SEQRES 16 B 221 LYS TYR ASP SER ARG ASP ILE PHE PRO ALA GLY TRP CYS SEQRES 17 B 221 ARG LEU THR GLY ASP VAL LEU GLN PRO PRO GLY THR SER HET MLZ A1244 11 HET MLZ B1244 11 HET PGE B1245 10 HETNAM MLZ N-METHYL-LYSINE HETNAM PGE TRIETHYLENE GLYCOL FORMUL 3 MLZ 2(C7 H16 N2 O2) FORMUL 5 PGE C6 H14 O4 FORMUL 6 HOH *187(H2 O) HELIX 1 1 HIS A 34 GLY A 43 1 10 HELIX 2 2 PRO A 48 PHE A 52 5 5 HELIX 3 3 GLY A 119 GLU A 124 1 6 HELIX 4 4 ASN A 137 SER A 139 5 3 HELIX 5 5 SER A 140 ASN A 150 1 11 HELIX 6 6 SER A 156 PHE A 160 5 5 HELIX 7 7 SER A 210 ASP A 214 5 5 HELIX 8 8 GLY A 228 GLY A 234 1 7 HELIX 9 9 HIS B 34 GLY B 43 1 10 HELIX 10 10 PRO B 48 PHE B 52 5 5 HELIX 11 11 GLY B 119 GLY B 125 1 7 HELIX 12 12 SER B 156 PHE B 160 5 5 HELIX 13 13 SER B 210 ASP B 214 5 5 HELIX 14 14 GLY B 228 GLY B 234 1 7 SHEET 1 AA 5 PHE A 106 LEU A 109 0 SHEET 2 AA 5 ARG A 92 LEU A 97 -1 O LEU A 93 N ARG A 108 SHEET 3 AA 5 ASN A 76 THR A 89 -1 O THR A 84 N ARG A 96 SHEET 4 AA 5 LYS A 68 ASP A 73 -1 O LEU A 69 N ALA A 83 SHEET 5 AA 5 ILE A 115 GLN A 116 -1 O GLN A 116 N GLU A 70 SHEET 1 AB 5 TYR A 215 LYS A 218 0 SHEET 2 AB 5 GLU A 201 PHE A 206 -1 O VAL A 202 N CYS A 217 SHEET 3 AB 5 ASN A 185 LYS A 198 -1 O THR A 193 N THR A 205 SHEET 4 AB 5 LYS A 177 ASP A 182 -1 O LEU A 178 N ALA A 192 SHEET 5 AB 5 ILE A 224 PHE A 225 -1 O PHE A 225 N GLU A 179 SHEET 1 BA 5 PHE B 106 LEU B 109 0 SHEET 2 BA 5 ARG B 92 LEU B 97 -1 O LEU B 93 N ARG B 108 SHEET 3 BA 5 CYS B 81 THR B 89 -1 O THR B 84 N ARG B 96 SHEET 4 BA 5 LYS B 68 ALA B 71 -1 O LEU B 69 N ALA B 83 SHEET 5 BA 5 ILE B 115 GLN B 116 -1 O GLN B 116 N GLU B 70 SHEET 1 BB 5 TYR B 215 LYS B 218 0 SHEET 2 BB 5 GLU B 201 PHE B 206 -1 O VAL B 202 N CYS B 217 SHEET 3 BB 5 ILE B 189 LYS B 198 -1 O THR B 193 N THR B 205 SHEET 4 BB 5 LYS B 177 ILE B 181 -1 O LEU B 178 N ALA B 192 SHEET 5 BB 5 ILE B 224 PHE B 225 -1 O PHE B 225 N GLU B 179 SITE 1 AC1 4 ASP A 182 ASN A 185 PHE A 213 HOH A2104 SITE 1 AC2 8 VAL A 197 GLY A 199 LYS B 40 GLU B 41 SITE 2 AC2 8 ASP B 182 TRP B 209 PHE B 213 HOH B2083 SITE 1 AC3 3 TRP A 216 ARG B 94 ARG B 96 CRYST1 38.530 99.210 131.277 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.025954 0.000000 0.000000 0.00000 SCALE2 0.000000 0.010080 0.000000 0.00000 SCALE3 0.000000 0.000000 0.007617 0.00000